IP Library Granted Patent US 8,362,083
Granted Patent B2
US 8,362,083 · App. 12/014,616 · Granted Jan 29, 2013

Taste-masked docusate compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,362,083
App. No.
12/014,616
Granted
Jan 29, 2013
Kind
B2
Abstract

A taste-masked liquid composition of docusate includes a docusate salt, povidone, a polyether, and water. Additional ingredients in the composition may include thickeners, sweeteners, flavorants, polyols, preservatives, chelating agents and pH adjusters. Such compositions may be used as taste-masked oral compositions of docusate, and may provide therapeutic effects such as stool-softening.

Claims (15)

1. A taste-masked liquid composition, comprising:

0.29 w/w % sodium docusate;

5 w/w % povidone;

5 w/w % polyethyleneglycol;

15 w/w % propylene glycol;

0.05 w/w % xanthan gum;

a sweetener comprising sorbitol, xylitol, and sucralose,

the sorbitol accounting for 5 w/w % to 25 w/w % of the composition, the xylitol accounting for about 5 w/w % to 40 w/w % of the composition, and the sucralose accounting for 0.1 w/w % to 1 w/w % of the composition;

a flavorant comprising fruit punch flavor, the fruit punch flavor accounting for 0.1 w/w % to 2 w/w % of the composition;

a pH adjuster comprising sodium citrate and citric acid,

the sodium citrate accounting for 0.05 w/w % to 2 w/w % of the composition, and the citric acid accounting for 0.05 w/w % to 2 w/w % of the composition;

a preservative comprising methyl paraben, edetate disodium and propyl paraben,

the methyl paraben accounting for 0.05 w/w % to 0.3 w/w % of the composition, and the propyl paraben accounting for 0.005 w/w % to 1 w/w % of the composition; and

a chelating agent comprising edentate disodium, the edentate disodium accounting for 0.01 w/w % to 1 w/w % of the composition,

wherein the sodium docusate is the sole pharmaceutically active agent.

Assignments (6)
RELEASE OF TERM SECURITY INTERESTS Recorded Mar 18, 2025
From: BARCLAYS BANK PLC
To: BLACKSMITH BRANDS, INC.; C. B. FLEET COMPANY, INCORPORATED; DENTEK ORAL CARE, INC.; MEDTECH PRODUCTS INC.
Reel/Frame 070542/0447 →
ABL SECURITY AGREEMENT Recorded Jan 31, 2017
From: C.B. FLEET COMPANY INCORPORATED
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 041567/0099 →
TERM LOAN SECURITY AGREEMENT Recorded Jan 30, 2017
From: C.B. FLEET COMPANY INCORPORATED
To: BARCLAYS BANK PLC, AS ADMINISTRATIVE AGENT
Reel/Frame 041554/0309 →
RELEASE OF SECURITY INTEREST Recorded Jan 27, 2017
From: GOLUB CAPITAL MARKETS LLC (F/K/A GCI CAPITAL MARKETS LLC)
To: C. B. FLEET COMPANY, INC.; C.B. FLEET INVESTMENT CORPORATION
Reel/Frame 041102/0595 →
SECURITY INTEREST Recorded Oct 24, 2014
From: C. B. FLEET COMPANY, INCORPORATED; C.B. FLEET INVESTMENT CORPORATION
To: GCI CAPITAL MARKETS LLC, AS AGENT
Reel/Frame 034028/0363 →
RELEASE OF SECURITY INTEREST Recorded Oct 24, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: C. B. FLEET COMPANY, INCORPORATED
Reel/Frame 034032/0851 →